Atlas Trials

A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy

Clinical trial NCT06713135 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06713135
Sponsor
Santhera Pharmaceuticals
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2024-11-10
Primary completion
2028-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.